FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate

Clin Nucl Med. 2011 Jul;36(7):582-3. doi: 10.1097/RLU.0b013e3182177284.

Abstract

We report a case that fluorodeoxyglucose positron emission tomography (FDG PET)/computed tomography (CT) depicted systemically multiple lesions of methotrexate (MTX)-associated lymphoproliferative disorders. A 70-year-old man receiving MTX for rheumatoid arthritis complained of neck swelling. FDG PET/CT revealed multiple FDG-avid lesions in lymph nodes, lungs, bones, and muscles. Lesions in bones and muscles were not detected on X-CT. Final diagnosis of cervical node was confirmed as MTX-associated lymphoproliferative disorders. FDG PET/CT performed 148 days after discontinuing MTX demonstrated complete remission.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Fluorodeoxyglucose F18*
  • Humans
  • Lymphoproliferative Disorders / chemically induced*
  • Lymphoproliferative Disorders / diagnostic imaging*
  • Lymphoproliferative Disorders / pathology
  • Male
  • Methotrexate / adverse effects*
  • Positron-Emission Tomography*
  • Remission, Spontaneous*
  • Tomography, X-Ray Computed*

Substances

  • Fluorodeoxyglucose F18
  • Methotrexate